Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-17-007493
Filing Date
2017-04-28
Accepted
2017-04-28 17:05:49
Documents
5
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A dffn20170427_10ka.htm 10-K/A 707233
2 EXHIBIT 10.18 ex10-18.htm EX-10.18 127603
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 19742
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 19618
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 13013
  Complete submission text file 0001437749-17-007493.txt   888538
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37942 | Film No.: 17796841
SIC: 2834 Pharmaceutical Preparations